Shares of Medical Marijuana, Inc. (OTCMKTS:MJNA) Rise Rapidly on Short Week


One cannabis stock that we routinely follow here on Street Register is Medical Marijuana, Inc. (OTCMKTS:MJNA). The last time we were mentioning it we talked about the company’s HempMeds® Mexico subsidiary generating its largest-ever revenue month in the history of the company in November.


In addition to an update on HempMeds, we also wanted to touch upon MJNA’s recent promotion of a key member of management.


Medical Marijuana, Inc. (OTCMKTS:MJNA) promoted Vice President of Operations, Blake N. Schroeder to Chief Operating Officer. Schroeder will also remain in his dual role as Chief Executive Officer of Medical Marijuana, Inc. subsidiary Kannaway®, which sells hemp-based botanical products for health and wellness.


Schroeder, who joined Medical Marijuana, Inc. and Kannaway® in March of 2016, has more than 10 years of experience leading international direct sales companies, with extensive experience in the nutrition industry ranging from legal and regulatory insight to overseeing all aspects of global sales, product development, marketing, distribution and operations.


“We are proud to have Blake as a senior leader and this promotion is well-deserved,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Since joining our organization, Blake has delivered dramatic performance results, pioneered new business strategies and helped improve our operations and brand presence worldwide. We’re confident in his ability to take us to yet another level of success. Blake is known for his ability to drive significant revenue increases and Medical Marijuana, Inc. was pleased to announce that throughout Q3 2017, we shattered monthly and daily sales records, with a year-over-year increase of 255%.” (Source: PR Newswire)


Back to HempMeds news, Raúl Elizalde, President of HempMeds® Mexico was recently featured in several international news publications about his speaking engagement at the World Health Organization Drug Scheduling Convention on Psychotropic Substances in November 2017.


Elizalde, who’s campaign to help his epileptic daughter legalized cannabidiol (CBD) in Mexico, discussed how the substance is non-psychoactive, non-addictive and has no negative side effects. He shared his story about how CBD changed his family’s life for the better and how the World Health Organization’s recommendation has the potential to change many more lives across the globe.


“We couldn’t be prouder to have Raúl representing the Medical Marijuana, Inc. portfolio of companies and to have our mission of increasing access to CBD featured in coverage on such prominent media outlets,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We believe that Raúl had a significant impact on the World Health Organization’s recommendation not to schedule CBD and we’re thankful that the media continues to view him as an important cannabis industry icon. Medical Marijuana, Inc. continues to be a leader for the industry, and the future is very bright indeed.” (Source: PR NewsWire)


Meanwhile, on the MJNA chart, we have seen a considerable increase in price action and volume on this holiday shortened week, following a pattern we are noticing across the cannabis market as a whole. We’ll be sure to stay on top of the story as we enter 2018, which figures to be a big year for the sector. Between California kicking off its recreational sales next week, and Canada doing the same in July, there should be plenty of fuel for the fire. Stay locked to Street Register for updates, and we’ll deliver important developments on MJNA as they unfold. In the meantime, if you’ve yet to sign up for our 100% free newsletter, do so now! Just enter your active email address into the box below and submit!



Disclosure: No one at Street Register has been compensated in any way for the publishing of this article, nor do we hold any position in MJNA stock, short or long.